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The specificity of pptr-1 and B56 iso-
forms for Akt Thr308 but not Ser473 
dephosphorylation is paralleled by recent 
discoveries of a PHLPP family of conserved 
phosphatases that target Ser473 but not 
Thr308 (Gao et al., 2005). As observed 
here for pptr-1 in worms, different Akt 
family members are targeted by distinct 
PHLPP family members in mammalian 
cells (Brognard et al., 2007). Similarly, one 
might anticipate that multiple mammalian 
B56 isoforms would play a role in regulat-
ing Akt isoforms. Indeed, B56γ and B56β 
have previously been shown to modulate 
Akt signaling in different contexts (Chen et 
al. 2005; Rocher et al., 2007).
Notably, B56 and PHLPP isoforms are 
implicated in cancer and diabetes. B56γ 
is inactivated by SV40 small T antigen in 
cellular transformation (Chen et al., 2004), 
and B56γ is also downregulated in some 
tumors. Somatic mutations that result in 
loss of B56 binding have been reported in 
A subunits of PP2A, and the resulting hap-
loinsufficiency promotes cancer (Wes-
termarck and Hahn, 2008). Conversely, 
the upregulation of PHLPP1 in skeletal 
muscle from diabetic patients correlates 
with the loss of Akt-2 phosphorylation 
at Ser473 (Cozzone et al., 2008). Impor-
tantly, it is unlikely that Akt will be the only 
target of a particular B56 isoform, as p53 
and Wnt signaling are both regulated by 
B56 isoforms. Similarly, protein kinase C 
signaling has been well established as a 
target for PHLPP beyond Akt.
Given the aforementioned complexi-
ties of different phosphatase isoforms 
regulating different Akt family members, 
it is likely that the tissue expression pat-
terns of different mammalian B56 and 
PHLPP isoforms will play a major role in 
dictating the level of responsiveness of 
the PI3K-Akt pathway. Hence, inactiva-
tion of a given isoform of B56 or PHLPP 
might result in a restoration of insulin sig-
naling in metabolic tissues from diabetic 
patients, but could trigger unrestrained 
proliferation in epithelial tissues. Under-
standing the intricacies of Akt regulation 
in different mammalian tissues awaits 
further work, but B56 subunits are now 
clearly front and center in the investiga-
tion of aging and disease.
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The TRIM-NHL family of proteins is conserved among metazoans and has been shown to regulate 
cell proliferation and development. In this issue, Hammell et al. (2009) and Schwamborn et al. 
(2009) identify two members of this protein family, NHL-2 in worms and TRIM32 in mice, as positive 
regulators of microRNA function.MicroRNAs (miRNAs) are small noncod-
ing RNAs that regulate gene expres-
sion posttranscriptionally. In animals, 
they typically base pair imperfectly with 
sequences in the 3′ untranslated regions 
(3′UTRs) of mRNAs to either inhibit trans-
lation or accelerate mRNA decay. Fol-
lowing excision from longer precursors, 818 Cell 136, March 6, 2009 ©2009 ElseviermiRNAs are loaded into ribonucleopro-
tein particles called miRNPs. Argonaute 
(AGO) and GW182 family proteins, the 
best-characterized components of 
miRNPs, act as key effectors in miRNA 
function. Although as many as 50% of 
all genes might be regulated by the hun-
dreds of miRNAs identified in mammals,  Inc.the exact mechanism of this regulation 
is not known. The effects of miRNAs 
are diverse—some targeted mRNAs 
undergo destabilization whereas oth-
ers are mainly translationally inhibited, 
with the degree of repression varying for 
different mRNA-miRNA combinations. 
Consistent with this, protein cofactors 
figure 1. The TRIM-nHL Protein family and Its Role in miRnA Regulation
(A) (Top) TRIM-NHL proteins contain the tripartite motif (TRIM), consisting of a RING domain (R), one or two B-boxes (B), a coiled-coil region (CC), and the C-
terminal NHL domain composed of 4–6 NHL repeats. The RING domain confers ubiquitin ligase activity and the NHL domain mediates interaction with AGO 
proteins. Drosophila melanogaster Brat and Caenorhabditis elegans NCL-1 are “incomplete” TRIM-NHL proteins that lack RING domains. The TRIM motif is 
also found in conjunction with other types of C-terminal domains and defines a superfamily of TRIM proteins. (Bottom) Classification of mouse (black), Droso-
phila (red), and C. elegans (blue) TRIM-NHL proteins based on the JACOP protocol (http://myhits.isb-sib.ch/cgi-bin/jacop), a method that clusters proteins 
without multiple sequence alignment.
(B) Possible mechanisms of TRIM-NHL action in miRNA-mediated gene repression. (Top) TRIM-NHL proteins could increase miRNA activity by modulating the 
interaction of miRNP with downstream effectors, achieving miRNA specificity through recognition of the miRNA-mRNA duplex. (Middle) TRIM-NHL proteins could 
facilitate loading of miRNA into miRNP by contacting the miRNA duplex. (Bottom) TRIM-NHL proteins could strengthen miRNA-mRNA interactions, achieving 
miRNA specificity by either direct or indirect interaction with the mRNA 3′UTR at sites enriched in the vicinity of sequences recognized by specific miRNAs.continue to be discovered that regulate 
the biogenesis and function of miRNAs 
(Ding et al., 2009; Filipowicz et al., 2008). 
In this issue of Cell, Hammell et al. (2009) 
and Schwamborn et al. (2009) find that 
two TRIM-NHL family proteins—NHL-2 
in the worm Caenorhabditis elegans and 
TRIM32 in mice, respectively—positively 
regulate miRNA activity and play roles in 
developmental timing and asymmetric 
cell division (Figure 1).
Hammell and colleagues report that 
the TRIM-NHL protein NHL-2 in C. ele-
gans is required for optimal let-7 and 
lsy-6 miRNA activity. Although NHL-2 
deficiency results in only a relatively mild 
phenotype (indicating that NHL-2 is not 
essential for the miRNA pathway), loss 
of NHL-2 greatly enhances the sever-
ity of developmental defects caused by 
reduced levels of let-7 or lsy-6. Impor-
tantly, NHL-2 affects miRNA activity 
without changing miRNA levels, sug-
gesting a role for the protein in the effec-
tor phase of miRNP activity rather than in miRNA metabolism. This hypothesis 
is strengthened by the observations that 
NHL-2 interacts genetically and physi-
cally (in an RNA-dependent way) with 
the worm homologs of AGO and GW182 
proteins. NHL-2 also interacts with the 
helicase CGH-1/RCK/Me31B, a compo-
nent of P-bodies (cytoplasmic domains 
involved in the degradation and storage 
of repressed mRNAs) that is already 
implicated in miRNA repression in flies 
and mammals. The conclusion that 
TRIM-NHL proteins may enhance miRNA 
activity at the level of miRNP function is 
supported by Schwamborn et al.’s study 
on early neuronal development in mice. 
Schwamborn et al. observe that dur-
ing asymmetric cell division in neural 
progenitor cells, the TRIM-NHL protein 
TRIM32 is enriched in one of the two 
daughter cells. The authors find that 
TRIM32 suppresses cell proliferation and 
induces neuronal differentiation. TRIM32 
exerts its effect by two mechanisms: it 
ubiquitinates the transcription factor Cell 1c-Myc, targeting it for degradation, and 
it enhances miRNP activity by interact-
ing (via the NHL domain) with AGO1. The 
authors establish the miRNA let-7a as an 
important target of TRIM32. Consistent 
with this, overexpression of let-7a simi-
larly promotes neuronal differentiation, 
whereas let-7a inhibition prevents it.
One of the intriguing observations 
made in these two reports is the appar-
ent capacity of TRIM-NHL proteins 
to enhance the activity of only some 
miRNAs. For TRIM32, this miRNA-spe-
cialized function is supported by the 
specific enrichment of some miRNAs 
with immunoprecipitated TRIM32 
(Schwamborn et al., 2009). Furthermore, 
Schwamborn et al. find that TRIM32 is 
able to stimulate repression of reporter 
gene expression that responds only to 
those enriched miRNAs. Likewise, Ham-
mell et al. mention that nhl-2 mutants 
only show genetic interactions with let-7 
and lsy-6 mutants and not with other 
miRNA mutants. Several models, which 36, March 6, 2009 ©2009 Elsevier Inc. 819
are not mutually exclusive, could explain 
both the miRNA-specific and the general 
effects of TRIM-NHL proteins (Figure 1). 
As mature miRNAs are very short and 
have their 5′ and 3′ ends anchored to 
specific AGO protein domains in miRNPs, 
there is not much room for them to inter-
act with other proteins. Thus, TRIM-NHL 
proteins could recognize unique struc-
tures of the miRNA-mRNA duplex or 
act at an earlier step by facilitating the 
loading of miRNAs into miRNPs. Alterna-
tively, TRIM-NHL proteins could interact 
with the mRNA 3′UTR (either directly or 
through adaptor proteins) and enhance 
miRNA-directed repression by strength-
ening mRNA-miRNA association. This 
latter model requires the enrichment 
of TRIM-NHL sites on the mRNA in 
the vicinity of binding sites for specific 
miRNAs. Examples of proteins binding 
to mRNA 3′UTRs but exerting a negative 
effect on miRNA repression have already 
been reported (Filipowicz et al., 2008).
As some TRIM-NHL proteins possess 
a RING domain that confers E3 ubiq-
uitin ligase activity (Balastik et al., 2008; 
Kudryashova et al., 2009; Schwamborn 
et al., 2009), might they alter miRNP 
activity by ubiquitinating its components 
to modulate functions or for proteasomal 
degradation? Indeed, some GW182 pro-
teins contain a ubiquitin-binding domain 
with an as yet unknown function. Though 
attractive, this model is not likely to apply 
to TRIM32 as Schwamborn et al. find 
that its RING domain is not required for 
the enhancement of miRNA-mediated 
repression of reporter gene expression.
Although the control of miRNA activ-
ity appears to be a general function of 
TRIM-NHL proteins, there may be more 
than one mechanism for how this control 
is achieved. In the fly Drosophila melano-
gaster, the TRIM-NHL proteins Brat and 
Mei-P26 control growth and differen-
tiation of neuroblasts and ovarian stem 
cells, respectively, similar to the role 
of TRIM32 in mouse neuroblasts. Like 
TRIM32, both Brat and Mei-P26 interact 
with AGO1 and function posttranscrip-
tionally to inhibit Drosophila Myc in dif-
ferentiating daughter cells (Neumuller et 
al., 2008 and references therein). How-
ever, Mei-P26 appears to inhibit rather 820 Cell 136, March 6, 2009 ©2009 Elsevier than activate the miRNA pathway. Over-
expression of Mei-P26 leads to a general 
reduction in miRNA levels, suggesting 
that Mei-P26 acts at the level of miRNA 
biogenesis or turnover rather than at the 
effector step of miRNA function (Neu-
muller et al., 2008).
In humans, mutations in the NHL 
domain of TRIM32 cause a reces-
sive hereditary muscle disorder, called 
limb-girdle muscular dystrophy type 2H 
(LGMD2H), that is phenocopied in mice 
lacking TRIM32. Although a neurogenic 
component in this disorder cannot be 
ruled out, these TRIM32-deficient mice 
do not suffer from developmental brain 
defects, nor do they develop brain tumors 
(Kudryashova et al., 2009). In contrast, 
when BRAT is mutated in flies, metastatic 
brain tumors arise. The apparent differ-
ence between these two phenotypes 
may be due to the redundant function in 
mammals of two related proteins, TRIM2 
and TRIM3, which are highly expressed 
in the brain but not in skeletal muscle. 
Notably, Trim2 knockout mice are born 
without any obvious brain defects but 
develop progressive neurodegeneration, 
suggesting that TRIM-NHL proteins may 
also serve important functions in the 
adult brain (Balastik et al., 2008).
Unlike their mammalian counterparts, 
worm TRIM-NHL proteins appear to 
lack functional redundancy. Indeed, 
Hammell et al. show that the mild phe-
notype caused by NHL-2 loss cannot 
be enhanced by the combined dele-
tion of NHL-1, NHL-3, and NCL-1. It 
remains to be established whether this 
lack of redundancy is due to different 
temporal/spatial expression, different 
miRNA specificity, or a lack of function 
in the miRNA pathway for these other 
TRIM-NHL proteins. LIN-41 is another 
C. elegans TRIM-NHL protein with a 
well-documented role in developmental 
timing (Slack et al., 2000). Intriguingly, 
Hammell and colleagues observe that 
the precocious phenotype (premature 
differentiation of seam cells) caused by 
lin-41 mutation is suppressed by nhl-2 
deletion, indicating antagonizing roles 
for these two TRIM-NHL proteins. This 
opposing effect might be explained, at 
least in part, by the fact that lin-41 is a Inc.let-7 target, whereas NHL-2 enhances 
let-7 activity. To establish whether 
worm TRIM-NHL proteins other than 
NHL-2 are also involved in miRNA 
regulation, mutations in these genes 
should be tested for genetic interac-
tion with miRNA factors. Indeed, LIN-41 
has already been found to interact with 
the miRNA processing enzyme Dicer, 
whereas NCL-1 is known to be required 
for RNA interference (Duchaine et al., 
2006; Kim et al., 2005).
In summary, the studies of Hammell et 
al. and Schwamborn et al. provide impor-
tant new information about the function 
of TRIM-NHL proteins. These proteins 
emerge as key regulators of develop-
ment and cell differentiation that exert 
their functions in many ways, including 
modulation of miRNA activity. It will be 
important to determine which of the bio-
logical effects of TRIM-NHL proteins are 
mediated through miRNAs and to estab-
lish their mechanism of action.
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